Frontiers in Clinical Drug Research: Diabetes and Obesity/ Atta-ur-Rahman
Material type:
TextSeries: ; Vol. 5Publication details: UAE; Bentham Science Publisher: Sharja,; 2020.Description: 219 pagesISBN: - 978-1-68108-754-2
| Item type | Current library | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|
Book
|
Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD) Library | RM301.27.A88_2020 (Browse shelf(Opens below)) | Available | P 2985 |
Browsing Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD) Library shelves Close shelf browser (Hides shelf browser)
|
|
No cover image available |
|
|
No cover image available | No cover image available | ||
| RS199.5.T36_2021 Oil-in-water nanosized emulsions for drug delivery and targeting / | RS160.N38_2018 Natural Products in Clinical Trials/ | RS160.N38_2020 Natural Products in Clinical Trials/ | RM301.27.A88_2020 Frontiers in Clinical Drug Research: Diabetes and Obesity/ | RM301.27.A88_2019 Frontiers in Clinical Drug Research Anti-Infectives/ | RM301.27.A88_2020 Frontiers in Clinical Drug Research Anti-Infectives/ | RM301.27.A88_2020 Frontiers in Clinical Drug Research – Anti Allergy Agents Volume 4 |
Frontiers in Clinical Drug Research – Diabetes and Obesity is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research.